The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

University of Geneva researchers led a collaboration for testing different size-exclusion chromatography columns to compare ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

An mRNA cancer vaccine triggered strong immune responses and improved treatment outcomes in mice, offering a new approach to treat tumors.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Although the COVID vaccine does not contain gp145, Dr Krawczyk said it was wrong to suggest it could in any way lead to HIV, ...

Your circadian rhythm influences mood, metabolism and even how well you respond to medical treatment. Now we finally have the ...

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials.

A breakthrough in our understanding of mRNA delivery systems in the body may allow for more direct treatments for ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2025 and reviewed recent ...

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom ...